Both L-4F, one apolipoprotein A-1 mimetic peptide, and statins can reduce progression of atherosclerosis by different mechanisms. The combination of the two drugs can cause lesion regression by rendering HDL anti-inflammatory. We postulated that combination of L-4F and simvastatin may stimulate cholesterol efflux and related proteins expressions to alleviate atherosclerosis. Thirty male wild-type (W-T) C57 BL/6 mice and apo E−/− mice were divided into five groups: W-T group, atherosclerosis (AS) group, simvastatin group, L-4F group and the combination of simvastatin and L-4F group. After 16 weeks, serum lipids, atherosclerotic lesion areas, cholesterol efflux and the expressions of related proteins including ABCA1, SR-BI, ABCG1, LXRα and PPARγ were evaluated. The aortic atherosclerotic lesion areas were reduced more significantly by combination of both drugs than single agent, and cholesterol efflux was promoted more in combination group than simvastatin and L-4F group. Besides, the combination group promoted expressions of cholesterol efflux related proteins. The combination of L-4F and simvastatin reduced atherosclerotic lesions, which stimulates cholesterol efflux by promoting the expressions of related proteins. In addition, these results help us further understand that the regression of the atherosclerosis would be assessed by reduction in LDL-C with increase of cholesterol efflux.
15 October 2013 in Journal of the American Society of Hypertension
Objectives: PCSK9 is critical in cholesterol homeostasis and anti-tumor immunity modulation. This study aims to investigate PCSK9’s role in HER2-positive breast cancer (BC) as a potential prognostic marker. Methods: The impact of PCSK9 on HER2-positive BC was analyzed by virtue of data from The Cancer Genome Atlas (TCGA). Moreover, PCSK9 expression in tumor cells from 92 HER2-positive patients was assessed through immunohistochemistry (IHC). Then, it was found that this expression was correlated with various clinicopathological parameters including histological grading, hormone receptor (HR) status, and patient survival. Results: PCSK9 expression positively correlated with pathohistological grading and hormone receptor status, but negatively with patient survival. GSEA showed low PCSK9 expression groups enriched in immune-related pathways, while high expression groups favored coagulation pathways. CIBERSORT analysis revealed a notable negative association between PCSK9 expression and γδ T cells, suggesting PCSK9’s role in modulating tumor microenvironment (TME) immune reactivity. Low PCSK9 expression was associated with a more favorable response to neoadjuvant therapy in patients. Conclusions: PCSK9 expression in HER2-positive BC is a significant prognostic indicator, with higher levels related to worse clinical outcomes. These results suggest PCSK9’s potential utility in predicting treatment responses and guiding therapeutic strategies for HER2-positive BC patients.
15 August 2025 in Reviews in Cardiovascular Medicine
Background: The Oxidative Balance Score (OBS) is a new measure for assessing systemic oxidative stress, where higher scores indicate increased exposure to antioxidants. However, the relationship between the OBS and mortality in individuals with hypertension remains unclear. Methods: This study evaluated 8151 hypertensive individuals from the National Health and Nutrition Examination Survey (NHANES) (2001–2018), utilizing data from the National Death Index, tracked through December 31, 2019. The association between OBS and mortality (cardiovascular and all-cause) was examined using multivariable Cox regression models. Results: During a median follow-up of 9.7 years, which included 1692 deaths (461 of which were cardiovascular), multivariable Cox regression showed the highest quartile of OBS had significantly lower rates of all-cause mortality (hazard ratio (HR) 0.761, 95% CI: 0.635–0.912) and cardiovascular mortality (HR 0.553, 95% CI: 0.388–0.788) compared to those in the lowest quartile. An increase of one unit in the OBS was associated with a 1.9% reduction in all-cause mortality risk and a 3.7% reduction in cardiovascular mortality risk. This relationship remained consistent across various subgroup analyses, and spline regression supported a linear inverse trend. Conclusions: For adults with hypertension, an elevated OBS is independently associated with a lower risk of mortality both from all-cause and cardiovascular diseases, suggesting that higher antioxidant levels may be protective.
The Systemic Immune-Inflammation Index (SII) is widely studied for its role in evaluating Cardiovascular Disease (CVD) and mortality. However, its association with all-cause and CVD mortality in non-elderly diabetic adults remains unclear. This study aims to explore the relationship between SII and both all-cause and CVD mortality in non-elderly diabetic adults in the United States. Cox proportional hazards models and subgroup analyses were used to assess the link between SII and mortality. Restricted Cubic Splines (RCS) examined the nonlinear association between SII and mortality. Data from 4680 participants in NHANES (2001‒2018) were analyzed. Over an average follow-up of 98.3 months, there were 625 all-cause deaths and 162 CVD-related deaths. Participants were categorized into two SII groups (higher: > 947.625, lower: ≤ 947.625). Multivariable-adjusted models showed that higher SII levels were significantly associated with an increased risk of both CVD mortality (HR = 3.05; 95 % CI 1.85, 5.01) and all-cause mortality (HR = 1.97; 95 % CI 1.50, 2.58). Subgroup analyses confirmed the consistency of these associations. RCS analysis revealed a nonlinear relationship between SII and all-cause mortality, while the association with CVD mortality was linear. Higher SII levels in non-elderly diabetic adults in the U.S. are linked to an increased risk of both CVD and all-cause mortality.
We report a child with an unusual coronary bridge crossing over the left anterior descending (LAD), circumflex (CX), and right coronary artery (RCA). The bridges range from 0.8-1.2 mm depth. The patient presented with exercise-induced syncope and myocardial infarction (MI). She exhibited no syncope after medicine and exercise control.